Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.53 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.53 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.53 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.53 |
| ▸ | PREP | P48147 | 2/20 | 0.52 |
| ▸ | FKBP1A | P62942 | 4/20 | 0.51 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.51 |
| ▸ | ACE | P12821 | 3/20 | 0.50 |
| ▸ | CMA1 | P23946 | 2/20 | 0.49 |
| ▸ | CASP1 | P29466 | 1/20 | 0.49 |
| ▸ | CASP3 | P42574 | 1/20 | 0.49 |
| ▸ | CASP2 | P42575 | 1/20 | 0.49 |
| ▸ | CASP4 | P49662 | 1/20 | 0.49 |
| ▸ | CASP5 | P51878 | 1/20 | 0.49 |
| ▸ | CASP7 | P55210 | 1/20 | 0.49 |
| ▸ | CASP9 | P55211 | 1/20 | 0.49 |
| ▸ | CASP8 | Q14790 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12023625 | 1.00 | ALDH1A1 (0.53) | ALDH1A1CYP3A4TSHRADORA3ADORA2A | |
| SCHEMBL13951237 | 0.92 | CTSL (0.56) | ALDH1A1CYP3A4TSHRPREPFKBP1A | |
| SCHEMBL8133863 | 0.92 | CTSL (0.56) | ALDH1A1CYP3A4TSHRPREPFKBP1A | |
| SCHEMBL3470867 | 0.92 | CTSL (0.56) | ALDH1A1CYP3A4TSHRPREPFKBP1A | |
| SCHEMBL18620865 | 0.92 | ALDH1A1 (0.61) | ALDH1A1CYP3A4TSHRPREPFKBP1A | |
| SCHEMBL22209492 | 0.92 | ALDH1A1 (0.61) | ALDH1A1CYP3A4TSHRPREPFKBP1A | |
| SCHEMBL18620597 | 0.90 | ACE (0.60) | ALDH1A1CYP3A4TSHRPREPFKBP1A | |
| SCHEMBL20484674 | 0.90 | ACE (0.60) | ALDH1A1CYP3A4TSHRPREPFKBP1A | |
| SCHEMBL7285235 | 0.90 | CMA1 (0.60) | PREPCMA1CTSLELANE | |
| SCHEMBL3469545 | 0.89 | PREP (0.65) | ALDH1A1CYP3A4TSHRADORA3ADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200048306-A1 | PRODRUG OF AN ICE INHIBITOR | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2020-02-13 | — | — | US | disclosed |
| US-20180327449-A1 | PRODRUG OF AN ICE INHIBITOR | VERTEX PHARMACEUTICALS INCORPORATED | 2018-11-15 | — | — | US | disclosed |
| US-9994613-B2 | Prodrug of an ICE inhibitor | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2018-06-12 | — | — | US | disclosed |
| US-20170022249-A1 | PRODRUG OF AN ICE INHIBITOR | VERTEX PHARMACEUTICALS INCORPORATED | 2017-01-26 | — | — | US | disclosed |
| US-9487555-B2 | Prodrug of an ice inhibitor | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2016-11-08 | — | — | US | disclosed |
| US-9156880-B2 | Prodrug of an ice inhibitor | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2015-10-13 | — | — | US | disclosed |
| US-20150284426-A1 | PRODRUG OF AN ICE INHIBITOR | VERTEX PHARMACEUTICALS INCORPORATED | 2015-10-08 | — | — | US | disclosed |
| EP-2270005-B1 | Prodrug of an ice inhibitor | VERTEX PHARMA (US) | 2015-07-08 | — | — | EP | disclosed |
| US-20130331310-A1 | Prodrug of an Ice Inhibitor | VERTEX PHARMACEUTICALS INCORPORATED | 2013-12-12 | — | — | US | disclosed |
| US-8329662-B2 | Prodrug of an ICE inhibitor | Vertexd Pharmaceuticals Incorporated (US) | 2012-12-11 | — | — | US | disclosed |
| EP-1396492-B1 | Prodrug of an ice inhibitor | VERTEX PHARMA (US) | 2012-02-01 | — | — | EP | disclosed |
| US-20110301096-A1 | PRODRUG OF AN ICE INHIBITOR | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2011-12-08 | — | — | US | disclosed |
| US-8022041-B2 | Prodrug of an ICE inhibitor | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2011-09-20 | — | — | US | disclosed |
| EP-2270005-A1 | Prodrug of an ice inhibitor | Vertex Pharmceuticals Incorporated (US) | 2011-01-05 | — | — | EP | disclosed |
| US-20090012149-A1 | PRODRUG OF AN ICE INHIBITOR | VERTEX PHARMACEUTICALS INCORPORATED | 2009-01-08 | — | — | US | disclosed |
| US-7417029-B2 | Prodrug of an ice inhibitor | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2008-08-26 | — | — | US | disclosed |
| EP-1396492-A1 | Prodrug of an ice inhibitor | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2004-03-10 | — | — | EP | disclosed |
| EP-1286989-A2 | PRODRUG OF AN ICE INHIBITOR | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2003-03-05 | — | — | EP | disclosed |
| US-20020013278-A1 | Prodrug of an ice inhibitor | VERTEX PHARMACEUTICALS INCORPORATED | 2002-01-31 | — | — | US | disclosed |
| WO-2001090063-A2 | PRODRUG OF AN ICE INHIBITOR | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2001-11-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200048306-A1 | PRODRUG OF AN ICE INHIBITOR | CASP1, MCL1, IL1B | ALDH1A1 287/4885CYP3A4 1434/4885TSHR 4764/4885 |
| US-20090012149-A1 | PRODRUG OF AN ICE INHIBITOR | CASP1, MCL1, IL1B | ALDH1A1 287/4885CYP3A4 1434/4885TSHR 4764/4885 |
| US-20180327449-A1 | PRODRUG OF AN ICE INHIBITOR | CASP1, MCL1, IL1B | ALDH1A1 287/4885CYP3A4 1434/4885TSHR 4764/4885 |
| US-20110301096-A1 | PRODRUG OF AN ICE INHIBITOR | CASP1, MCL1, IL1B | ALDH1A1 287/4885CYP3A4 1434/4885TSHR 4764/4885 |
| US-20170022249-A1 | PRODRUG OF AN ICE INHIBITOR | CASP1, MCL1, IL1B | ALDH1A1 287/4885CYP3A4 1434/4885TSHR 4764/4885 |
| US-20130331310-A1 | Prodrug of an Ice Inhibitor | CASP1, MCL1, IL1B | ALDH1A1 287/4885CYP3A4 1434/4885TSHR 4764/4885 |
| US-20020013278-A1 | Prodrug of an ice inhibitor | CASP1, MCL1, IL1A | ALDH1A1 289/4885CYP3A4 1526/4885TSHR 4729/4885 |
| US-20150284426-A1 | PRODRUG OF AN ICE INHIBITOR | CASP1, MCL1, IL1B | ALDH1A1 287/4885CYP3A4 1434/4885TSHR 4764/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.